Charles Schwab Investment Management Inc. Buys 36,264 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Charles Schwab Investment Management Inc. grew its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 3.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 974,451 shares of the company's stock after acquiring an additional 36,264 shares during the period. Charles Schwab Investment Management Inc. owned 0.37% of Ryan Specialty worth $62,521,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in RYAN. Assetmark Inc. acquired a new stake in shares of Ryan Specialty in the third quarter valued at approximately $34,000. Principal Securities Inc. grew its holdings in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after purchasing an additional 415 shares during the last quarter. Quarry LP lifted its stake in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after acquiring an additional 422 shares during the last quarter. Loomis Sayles & Co. L P grew its holdings in shares of Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock worth $91,000 after purchasing an additional 286 shares during the last quarter. Finally, R Squared Ltd acquired a new position in Ryan Specialty in the 4th quarter valued at approximately $92,000. 84.82% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on RYAN. Royal Bank of Canada lowered their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. Wells Fargo & Company upped their price target on Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research note on Friday, February 21st. Barclays lifted their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a report on Thursday, November 21st. Morgan Stanley began coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price target for the company. Finally, UBS Group lifted their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Ryan Specialty presently has an average rating of "Hold" and a consensus price target of $75.27.

Remove Ads

Insiders Place Their Bets

In related news, Director Nicholas Dominic Cortezi sold 31,409 shares of the business's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the transaction, the director now owns 2,697 shares in the company, valued at $177,031.08. The trade was a 92.09 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders have sold 316,451 shares of company stock valued at $20,907,793. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Stock Performance

Shares of NYSE RYAN traded down $0.96 during midday trading on Thursday, hitting $68.32. The company's stock had a trading volume of 678,386 shares, compared to its average volume of 986,004. The stock has a fifty day moving average price of $66.97 and a 200 day moving average price of $67.68. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $75.97. The firm has a market capitalization of $17.89 billion, a price-to-earnings ratio of 99.01, a P/E/G ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. On average, research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, March 4th. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. Ryan Specialty's dividend payout ratio is 69.57%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.